Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-06-09 08:19 am Purchase | 13G | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 10,633,789 16.66% | 7,409,689 (+229.82%) | View |
| 2023-05-16 4:28 pm Unchanged | 13D | Fusion Pharmaceuticals Inc. FUSN | ORBIMED ADVISORS LLC | 2,930,670 4.6% | 0 (Unchanged) | View |
| 2023-03-06 4:06 pm Unchanged | 13D | Fusion Pharmaceuticals Inc. FUSN | HealthCap VII L.P. | 3,807,247 6.1% | 0 (Unchanged) | View |
| 2023-02-28 5:09 pm Sale | 13D | Fusion Pharmaceuticals Inc. FUSN | ORBIMED ADVISORS LLC | 2,930,670 4.7% | -67,311 (-2.25%) | View |
| 2023-02-09 10:59 am Sale | 13G | Fusion Pharmaceuticals Inc. FUSN | FMR LLC | 2,692,054 6.014% | -537,912 (-16.65%) | View |
| 2023-02-01 08:56 am Purchase | 13G | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 3,224,100 7.2% | 3,224,100 (New Position) | View |
| 2023-01-27 11:12 am Sale | 13G | Fusion Pharmaceuticals Inc. FUSN | JOHNSON & JOHNSON JNJ | 3,670,516 8.2% | -89,118 (-2.37%) | View |
| 2022-02-14 2:51 pm Sale | 13G | Fusion Pharmaceuticals Inc. FUSN | ADAMS STREET PARTNERS LLC | 2,947,809 6.8% | -544,940 (-15.60%) | View |
| 2022-02-09 09:19 am Purchase | 13G | Fusion Pharmaceuticals Inc. FUSN | FMR LLC | 3,229,966 7.499% | 100,532 (+3.21%) | View |
| 2022-01-18 5:30 pm Purchase | 13D | Fusion Pharmaceuticals Inc. FUSN | TPG GP A LLC | 2,621,436 6.1% | 2,621,436 (New Position) | View |
| 2021-02-10 4:02 pm Purchase | 13G | Fusion Pharmaceuticals Inc. FUSN | ADAMS STREET PARTNERS LLC | 3,492,749 8.4% | 3,492,749 (New Position) | View |
| 2021-02-09 4:10 pm Purchase | 13G | Fusion Pharmaceuticals Inc. FUSN | VARIAN MEDICAL SYSTEMS INC VAR | 3,256,972 7.81% | 3,256,972 (New Position) | View |
| 2021-02-08 10:23 am Purchase | 13G | Fusion Pharmaceuticals Inc. FUSN | FMR LLC | 3,129,434 7.499% | 3,129,434 (New Position) | View |
| 2021-02-03 6:37 pm Purchase | 13G | Fusion Pharmaceuticals Inc. FUSN | CANADA PENSION PLAN INVESTMENT BOARD | 3,116,966 7.5% | 3,116,966 (New Position) | View |
| 2020-07-23 1:32 pm Purchase | 13G | Fusion Pharmaceuticals Inc. FUSN | Seroba Life Sciences Management Ltd | 2,021,646 4.85% | 2,021,646 (New Position) | View |
| 2020-07-10 5:00 pm Purchase | 13D | Fusion Pharmaceuticals Inc. FUSN | HealthCap VII L.P. | 3,807,247 9.1% | 3,807,247 (New Position) | View |
| 2020-07-10 4:37 pm Purchase | 13D | Fusion Pharmaceuticals Inc. FUSN | TPG Group Holdings (SBS) Advisors Inc. | 2,621,436 6.3% | 2,621,436 (New Position) | View |
| 2020-07-06 5:57 pm Purchase | 13D | Fusion Pharmaceuticals Inc. FUSN | ORBIMED ADVISORS LLC | 2,997,981 7.2% | 2,997,981 (New Position) | View |
| 2020-07-02 6:21 pm Purchase | 13G | Fusion Pharmaceuticals Inc. FUSN | JOHNSON & JOHNSON JNJ | 3,759,634 9% | 3,759,634 (New Position) | View |